Current Duke Appointments & Affiliations
Assistant Professor of Medicine
·
2020 - Present
Medicine, Gastroenterology,
Medicine
Recent Scholarly Works
Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases.
Journal article Clin Gastroenterol Hepatol · April 2021 Comparison data regarding anti-tumor necrosis factor drug concentrations in inflammatory bowel disease (IBD) between the enzyme-linked immunosorbent assay (ELISA) and the homogenous mobility shift assay (HMSA) are scarce.1-3 As decisions in clinical practi ... Full text Link to item CiteAntibiotic prophylaxis and infectious complications in patients on peritoneal dialysis undergoing lower gastrointestinal endoscopy.
Journal article Gastroenterol Rep (Oxf) · October 2020 Full text Link to item CiteClinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay.
Journal article J Clin Med · September 2, 2020 An upward drift for both infliximab and adalimumab concentrations measured by the homogenous mobility shift assay (HMSA) was previously reported. We aimed to investigate the impact of this drift on clinical care of patients with inflammatory bowel disease. ... Full text Link to item CiteEducation
Yale University, School of Medicine ·
2013
M.D.